FORE

Foresight Acquisition Corp. (FORE) | Rumor.io

Foresight Acquisition

FORE

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about FORE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% +0

May 26

Foresight Acquisition Corp. ($FORE) announced a business combination with P3 Health Partners, a $2.3 billion enterprise value deal with a $200 million PIPE.
The deal is trading at a -1.0% discount to NAV, offering a 3% arbitrage yield.
P3 Health Partners is expected to experience 31% YoY revenue growth, with a 2.8x sales multiple based on 2022E estimates.

Generated by AI

Sentiment

Of the messages about FORE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +18.18
Bearish	—	—	—	0% -18.18

Topics

Of the messages about FORE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	0%
Announcements	—	—	0%	65.55%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	100%	34.45%

May 26

Foresight Acquisition Corp. ($FORE) announced a definitive agreement with P3 Health Partners for a $2.3 billion SPAC merger.
The merger will bring P3 Health Partners public, with an enterprise value of $2.3 billion and a $200 million private investment in public equity (PIPE).
The deal is expected to close in the second half of the year, with Foresight Acquisition Corp. trading at a 3% discount to net asset value (NAV).

Generated by AI

Community

Of the messages about FORE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	96.3%	24.7%
Newcomers	0%	0%	3.7%	75.3%

May 25

Foresight Acquisition Corp. ($FORE) is set to combine with P3 Health Partners in a deal valuing the combined company at $2.3 billion, including a $200 million PIPE investment.
The deal is expected to close in H2, with P3 Health Partners' revenue projected to grow 31% YoY and 30% YoY in '21 and '22, respectively, with an EV of $2.42 billion.
The merger will make P3 Health Partners a publicly traded company, with an estimated post-transaction enterprise value of $2.3 billion and over $180 million in cash to fund growth.

Generated by AI

Also Discussed

Investors talking about FORE also mention

#	Name	Attention
1	SCMA - Seaport Calibre Materials Acquisition Corp.	——
2	INDF - Nifty India Financials ETF	——
3	SPDR DoubleLine Total Return Tactical ETFTOTL	0%new
4	AADI - Aadi Bioscience, Inc.	——
5	ESSA - ESSA Bancorp, Inc.	——
6	Siren DIVCON Leaders Dividend ETFLEAD	0%new
7	Brookfield Infrastructure Partners L.P. Preferred Stock 5.125% PerpetualBIPI	0%new
8	BFIN - BankFinancial Corporation	——
9	JPMorgan BetaBuilders Canada ETFBBCA	0%new
10	TMPO - Tempo Automation Holdings, Inc.	——